SACK1A and cancer: Chen demonstrated that FAM83A overexpression significantly promoted the cancer stem cell-like characteristics and chemotherapy resistance of tumor cells in vitro as well as in vivo in the mouse models of pancreatic cancer, while FAM83A inhibition reduced the drug resistance of tumor cells (Chen et al. 2017).